Evidence Hub

Solvent-free β-glucan-coated VD3 nanoliposomes: Physicochemical characterization and preliminary in vitro evaluation

J. Shobahah, D. Winarni, M. Aly, Naswandi Nur, W. Darmanto, D. Hudiyanti, L. Aun, Sri Puji Astuti Wahyuningsih

Journal of Pharmacy & Pharmacognosy Research, 2026

Abstract

Context: Vitamin D3 (VD3) has attracted interest in colorectal cancer research. Nevertheless, its limited solubility in aqueous media and low oral bioavailability restrict its pharmaceutical application. Solvent-free nanocarrier systems offer an alternative formulation approach that does not involve the use of organic solvents.

Aims: To develop β-glucan-coated VD3-loaded nanoliposomes and evaluate their physicochemical properties, storage stability, in vitro release, and preliminary effects on HCT-116 cell viability using the MTT assay.

Methods: VD3-loaded nanoliposomes were prepared using mild heating, probe sonication, virgin coconut oil (VCO) pre-dispersion, and β-glucan coating. The selected formulations were characterized using FTIR, dynamic light scattering, zeta potential, encapsulation efficiency, validated UV–Vis spectrophotometry, cryo-electron microscopy (Cryo-EM), in vitro drug release, storage stability, and MTT assays.

Results: The β-glucan-coated formulation exhibited a particle size of 201.8 ± 15.8 nm, PDI of 0.14 ± 0.09, zeta potential of −58.76 ± 1.86 mV, and encapsulation efficiency of 88.73 ± 0.70%, with a more uniform vesicular morphology than that of the uncoated formulation. It also showed a more controlled in vitro release profile and greater reduction in HCT-116 cell viability at intermediate concentrations.

Conclusions: β-Glucan coating improved the physicochemical performance of VD3-loaded nanoliposomes, providing a more controlled in vitro release…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free